GlassScriptPhysician profile
James D Quarles
NPI 1982639902
$5,116.79
in general payments reported to CMS, 2019-2025
39 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $371 · 2021: $993 · 2022: $926 · 2023: $961 · 2024: $854 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,919 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.12 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $765.88 | 2019-2023 | Veozah, Myrbetriq |
| Teleflex LLC | $452.96 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $359.08 | 2019-2025 | General - Erectile Dysfunction, Spaceoar System |
| Abbvie INC. | $306.54 | 2019-2024 | |
| Procept Biorobotics Corporation | $265.38 | 2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $249.89 | 2023-2024 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $226.13 | 2019-2023 | |
| Coloplast Corp | $206.49 | 2019-2023 | Titan |
| Myovant Sciences INC. | $199.64 | 2021-2022 | |
| Neotract INC. | $198.04 | 2019-2020 | |
| Pfizer INC. | $183.53 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $175.84 | 2019-2024 | Provenge |
| Urovant Sciences INC | $159.09 | 2021-2022 | |
| Janssen Biotech, INC. | $149.94 | 2019-2022 | |
| Axonics, INC. | $138.30 | 2022-2023 | Axonics |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Quarles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.